Opinion: Control vs. eradication: Applying infectious disease treatment strategies to cancer

Proceedings of the National Academy of Sciences of the United States of America

Volumn 112, Issue 4, 2015, Pages 937-938

  Jansen, Gunther ^a,b   Gatenby, Robert ^c   Aktipis, C Athena ^b,d,e  

^a UNIVERSITY OF KIEL   (Germany)

^b Institute for Advanced Study   (Germany)

^c H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e ARIZONA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS INHIBITOR; VIRULENCE FACTOR;

ARTICLE; BACTERIAL GROWTH; CANCER THERAPY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFECTION CONTROL; METASTASIS; NONHUMAN; PATHOGEN CLEARANCE; PRIORITY JOURNAL; TUMOR GROWTH; INFECTION; NEOPLASMS; PATHOLOGY;

HUMANS; INFECTION; NEOPLASM METASTASIS; NEOPLASMS;

EID: 84921952598     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1420297111     Document Type: Article

References (20)

1. Gatenby RA, Silva AS, Gillies RJ, Frieden BR (2009) Adaptive therapy. Cancer Res 69(11):4894-4903.
2. Read AF, Day T, Huijben S (2011) The evolution of drug resistance and the curious orthodoxy of aggressive chemotherapy. Proc Natl Acad Sci USA 108(Suppl 2):10871-10877.
3. Pena-Miller R, et al. (2013) When the most potent combination of antibiotics selects for the greatest bacterial load: The smile-frown transition. PLoS Biol 11(4):e1001540.
4. Rasko DA, Sperandio V (2010) Anti-virulence strategies to combat bacteria-mediated disease. Nat Rev Drug Discov 9(2):117-128.
5. Gatenby RA (2009) A change of strategy in the war on cancer. Nature 459(7246):508-509.
6. Greaves M, Maley CC (2012) Clonal evolution in cancer. Nature 481(7381):306-313.
7. Read AF, Graham AL, Raberg L (2008) Animal defenses against infectious agents: Is damage control more important than pathogen control. PLoS Biol 6(12):e4.
8. Ross-Gillespie A, Weigert M, Brown SP, Kümmerli R (2014) Gallium-mediated siderophore quenching as an evolutionarily robust antibacterial treatment. Evol Med Public Health 2014(1): 18-29.
9. Imperi F, et al. (2013) Repurposing the antimycotic drug flucytosine for suppression of Pseudomonas aeruginosa pathogenicity. Proc Natl Acad Sci USA 110(18):7458-7463.
10. Hann H-WL, Stahlhut MW, Blumberg BS (1988) Iron nutrition and tumor growth: Decreased tumor growth in iron-deficient mice. Cancer Res 48(15):4168-4170.
11. Allen RC, Popat R, Diggle SP, Brown SP (2014) Targeting virulence: Can we make evolution-proof drugs? Nat Rev Microbiol 12(4):300-308.
12. Nicolosi D, Tempera G, Genovese C, Furneri PM (2014) Anti-adhesion activity of A2-type proanthocyanidins (a cranberry major component) on uropathogenic E. coli and P. mirabilis strains. Antibiotics 3(2):143-154.
13. Robey IF, et al. (2009) Bicarbonate increases tumor pH and inhibits spontaneous metastases. Cancer Res 69(6):2260-2268.
14. Silva AS, Yunes JA, Gillies RJ, Gatenby RA (2009) The potential role of systemic buffers in reducing intratumoral extracellular pH and acid-mediated invasion. Cancer Res 69(6):2677-2684.
15. Pepper JW (2008) Defeating pathogen drug resistance: Guidance from evolutionary theory. Evolution 62(12):3185-3191.
16. Pepper JW (2012) Drugs that target pathogen public goods are robust against evolved drug resistance. Evol Appl 5(7):757-761.
17. Christensen LD, et al. (2012) Synergistic antibacterial efficacy of early combination treatment with tobramycin and quorum-sensing inhibitors against Pseudomonas aeruginosa in an intraperitoneal foreign-body infection mouse model. J Antimicrob Chemother 67(5):1198-1206.
18. Rumbaugh KP, et al. (2009) Quorum sensing and the social evolution of bacterial virulence. Curr Biol 19(4):341-345.
19. Maley CC, Reid BJ, Forrest S (2004) Cancer prevention strategies that address the evolutionary dynamics of neoplastic cells: Simulating benign cell boosters and selection for chemosensitivity. Cancer Epidemiol Biomarkers Prev 13(8):1375-1384.
20. Aktipis CA, Maley CC, Neuberg SL (2010) Psychological barriers to evolutionary thinking in medicine. Evolution and Medicine Review. Available at evmedreview.com/?p=231. Accessed December 10, 2014.